Steep declines in hepatitis C among people who inject drugs show Australia’s treatment for all approach is working
Hepatitis C has declined by a staggering 60% among people who inject drugs since new hepatitis C cures were made available through the Pharmaceutical Benefits Scheme (PBS) in 2016, according to a new report released today by the Kirby Institute at UNSW Sydney.
#WorldHepatitisDay: Supporting the HCV elimination agenda –– an EMCDDA initiative to increase access to hepatitis C care in drug services
Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day. Its aim is to increase awareness and understanding of viral hepatitis and the diseases it causes.
Capitalism gone wrong: how big pharma created America's opioid carnage
A web of firms ramped up narcotic painkiller sales, creating the biggest drug epidemic in American history as profits surged.
Share this on: